Operate with Nexstim-level finesse


 
Our product core team hosts regular product webinars - we invite you to see for yourself how Nexstim mapping may help your patients:
Product Webinar:
Neurosurgery

May 16, 2024

10 am EET (Helsinki) | 11 am CET (Berlin) |
3 pm HKT (Hong Kong) | 5 pm AEDT (Sydney)
Sign up
Product Webinar:
Neurosurgery

May 16, 2024

4 pm GMT (London) | 5 pm CET (Berlin) |
11 am ET (NYC) | 8 am PT (LA)
Sign up
If neither of these time slots are convenient for you, don't hesitate to contact us, so that we can setup a live demonstration at a time that suits you better: info@nexstim.com.
 

Indications for use: 

NBS 5 (FDA K112881): The Nexstim Navigated Brain Stimulation (NBS) System 5 is indicated for non-invasive mapping of the primary motor cortex of the brain to its cortical gyrus. The Nexstim NBS System 5 provides information that may be used in the assessment of the primary motor cortex for pre-procedural planning.

The Nexstim NBS System 5 is not intended to be used during a surgical procedure. The Nexstim NBS System 5 is intended to be used by trained clinical professionals.

Nexstim NexSpeech®, when used together with the NBS System 5, is indicated for non-invasive localization of cortical areas that do not contain essential speech function. NexSpeech® provides information that may be used in pre-surgical planning in patients undergoing brain surgery. Intra-operatively, the localization information provided by NexSpeech® is intended to be verified by direct cortical stimulation.

The Nexstim NBS System 5 with NexSpeech® is not intended to be used during a surgical procedure. The Nexstim NBS System 5 with NexSpeech® is intended to be used by trained clinical professionals.

 

ABOUT

CAREER

CONTACT

OUR OFFICES

LEGAL

PRIVACY POLICY

DATA PROTECTION DESCRIPTION